Narix Pharmaceuticals Private Limited

Macrobid (Nitrofurantoin) Capsule Urinary-Selective Antibiotic for Uncomplicated UTI Narix Pharmaceuticals Narix Pharmaceuticals manufactures Nitrofurantoin Capsules, a urinary-specific antibiotic with excellent activity in the urinary tract and very low systemic resistance development due to its multi-target bactericidal mechanism. Key Therapeutic Uses: � Uncomplicated lower UTI (cystitis) � first-line � Recurrent UTI prophylaxis � long-term low-dose � Pregnancy-safe UTI treatment (second trimester) � Asymptomatic bacteriuria in pregnancy Available Strengths: 50 mg 100 mg Product Highlights: � Urinary-selective � acts locally in urinary tract � Very low resistance development � WHO-GMP, DCGI approved � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #NitrofurantoinCapsule #MacrobidGeneric #UrinaryAntibiotic #UTIMedicine #CystitisTablet #NitrofurantoinManufacturer #AntibioticCapsule #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Zyvox (Linezolid) Tablet Oxazolidinone Antibiotic for MRSA, VRE & MDR-TB Narix Pharmaceuticals Narix Pharmaceuticals manufactures Linezolid Tablets, a synthetic oxazolidinone antibiotic that inhibits bacterial protein synthesis at the 23S rRNA of the 50S ribosomal subunit � critical for MRSA, VRE, and MDR-TB treatment. Key Therapeutic Uses: � MRSA infections � pneumonia, skin, soft tissue, bacteremia � Vancomycin-resistant Enterococcus (VRE) � MDR-TB � key component of BPaL regimen (WHO) � Nosocomial pneumonia � Diabetic foot MRSA infections Available Strengths: 400 mg 600 mg Product Highlights: � 100% oral bioavailability � tablet equals IV � WHO-GMP, DCGI approved � Critical MDR-TB drug � WHO recommended � Bulk export for TB programs in Africa, ASEAN � PCD pharma franchise available Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #LinezolidTablet #ZyvoxGeneric #MRSAAntibiotic #OxazolidinoneAntibiotic #VRETablet #MDRTBMedicine #LinezolidManufacturer #AntibioticTablet #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Deltyba (Delamanid) Tablet Nitroimidazooxazole for MDR-TB & XDR-TB Narix Pharmaceuticals Narix Pharmaceuticals supplies Delamanid Tablets, a nitroimidazooxazole that inhibits mycolic acid synthesis in M. tuberculosis � WHO-approved for MDR-TB treatment as an alternative or adjunct to bedaquiline in the BPaL regimen. Key Therapeutic Uses: � MDR-TB � WHO-recommended treatment drug � XDR-TB � combination regimen � Pediatric MDR-TB (>3 years) � FDA-approved � Alternative to bedaquiline in BPaL-based regimens Available Strengths: 50 mg Product Highlights: � WHO recommended MDR-TB medicine � Pediatric indication approved � WHO-GMP, DCGI approved � Supplied to national MDR-TB programs � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #DelamanidTablet #DeltybsGeneric #NitroimidazoleTB #MDRTBTablet #XDRTBMedicine #DelamanidManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Copegus (Ribavirin) Tablet Nucleoside Analogue for Hepatitis C & Viral Hemorrhagic Fevers Narix Pharmaceuticals Narix Pharmaceuticals supplies Ribavirin Tablets, a broad-spectrum synthetic nucleoside analogue that inhibits RNA-dependent RNA polymerase � previously the backbone of hepatitis C treatment and still used for RSV, Lassa fever, and as adjunct in HCV genotype 2/3. Key Therapeutic Uses: � Hepatitis C (HCV) � adjunct in peginterferon-based and some DAA regimens � Respiratory syncytial virus (RSV) � severe in immunocompromised � Lassa fever and other viral hemorrhagic fevers � Hantavirus infection Available Strengths: 200 mg 400 mg 600 mg Product Highlights: � WHO essential medicine � EML listed antiviral � WHO-GMP, DCGI approved � Critical hepatitis and hemorrhagic fever medicine � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #RibavirinTablet #CopegusGeneric #RibavinGeneric #HepatitisCTablet #BroadSpectrumAntiviral #RibavirinManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine